Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 2/20 | 0.49 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.49 |
| ▸ | LGALS4 | P56470 | 2/20 | 0.49 |
| ▸ | ENGASE | Q8NFI3 | 1/20 | 0.47 |
| ▸ | AMY2A | P04746 | 4/20 | 0.45 |
| ▸ | CD209 | Q9NNX6 | 2/20 | 0.44 |
| ▸ | AMY1A | P0DUB6 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 5/20 | 0.40 |
| ▸ | MGAM | O43451 | 2/20 | 0.39 |
| ▸ | SI | P14410 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | PDE4A | P27815 | 1/20 | 0.39 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.39 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | GJB2 | P29033 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1097727 | 0.93 | LGALS3 (0.46) | LGALS8LGALS3LGALS4ENGASEAMY2A | |
| SCHEMBL10053936 | 0.91 | AMY2A (0.47) | LGALS8LGALS3LGALS4ENGASEAMY2A | |
| SCHEMBL10605159 | 0.90 | LGALS8 (0.57) | LGALS8LGALS3LGALS4ENGASEAMY2A | |
| SCHEMBL10605150 | 0.90 | LGALS8 (0.57) | LGALS8LGALS3LGALS4ENGASEAMY2A | |
| SCHEMBL13073700 | 0.88 | LGALS8 (0.44) | LGALS8LGALS3LGALS4AMY2AAMY1A | |
| SCHEMBL12125921 | 0.87 | LGALS3 (0.63) | LGALS8LGALS3LGALS4ENGASECD209 | |
| SCHEMBL14190888 | 0.87 | LGALS3 (0.63) | LGALS8LGALS3LGALS4ENGASECD209 | |
| SCHEMBL5515621 | 0.87 | LGALS3 (0.63) | LGALS8LGALS3LGALS4ENGASECD209 | |
| SCHEMBL17070192 | 0.87 | LGALS3 (0.63) | LGALS8LGALS3LGALS4ENGASECD209 | |
| SCHEMBL5530198 | 0.87 | LGALS3 (0.63) | LGALS8LGALS3LGALS4ENGASECD209 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130065865-A1 | BARRIER FILM-FORMING GERMICIDAL COMPOSITION FOR CONTROLLING MASTITIS | DELAVAL HOLDING AB (SE) | 2013-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130065865-A1 | BARRIER FILM-FORMING GERMICIDAL COMPOSITION FOR CONTROLLING MASTITIS | CUTA, LCT, MGAM | LGALS8 112/4885LGALS3 68/4885LGALS4 71/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.